Early life arsenic exposure and brain dopaminergic alterations in rats

International Journal of Developmental Neuroscience

Volumn 38, Issue , 2014, Pages 91-104

  Chandravanshi, Lalit P ^a   Shukla, Rajendra K ^a   Sultana, Sarwat ^b   Pant, Aditya B ^a   Khanna, Vinay K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Apoptosis; Brain; Dopaminergic system; Mitochondrial dysfunctions; Oxidative stress

Indexed keywords

ARSENITE SODIUM; BETA ACTIN; DOPAMINE 2 RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DENSITOMETRY; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; IMMUNOBLOTTING; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOTOR ACTIVITY; MYELINATED NERVE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN EXPRESSION; RADIOASSAY; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84907812492     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2014.08.009     Document Type: Article

References (140)

1. Abhyankar L.N., Jones M.R., Guallar E., Navas-Acien A. Arsenic exposure and hypertension: a systematic review. Environ. Health Perspect. 2012, 120:494-500.
2. Abir T., Rahman B., D'Este C., Farooq A., Milton A.H. The association between chronic arsenic exposure and hypertension: a meta-analysis. J. Toxicol. 2012, 198793.
3. Aebi H. Catalase in vitro. Methods in Enzymology 1984, vol. 105:121-126. Academic Press, New York.
4. Agrawal A.K., Squibb R.E. Effects of acrylamide given during gestation on dopamine receptor binding in rat pups. Toxicol. Lett. 1981, 7(3):233-238.
5. Agrawal A.K., Squibb R.E., Bondy S.C. The effects of acrylamide treatment upon the dopamine receptor. Toxicol. Appl. Pharmacol. 1981, 30(58(1)):89-99.
6. Ahmed S., Mahabbat-e Khoda S., Rekha R.S., Gardner R.M., Ameer S.S., Moore S., Ekström E.C., Vahter M., Raqib R. Arsenic-associated oxidative stress,inflammation, and immune disruption in human placenta and cord blood. Environ. Health Perspect. 2011, 119(2):258-264.
7. Andrade V., Mateus M.L., Santos D., Aschner M., Batoreu M.C., Marreilha Dos Santos A.P. Arsenic and manganese alter lead deposition in the rat. Biol. Trace Elem. Res. 2014, 158(June (3)):384-391.
8. Ansari R.W., Shukla R.K., Yadav R.S., Seth K., Pant A.B., Singh D., Agrawal A.K., Islam F., Khanna V.K. Involvement of dopaminergic and serotonergic systems in the neurobehavioral toxicity of lambda-cyhalothrin in developing rats. Toxicol. Lett. 2012, 20(211(1)):1-9.
9. ATSDR (Agency for Toxic Substances and Disease Registry) Toxicological Profile for Arsenic (Update) (Draft for Public Comment) 2007.
10. +-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's disease. Free Radic. Res. 2008, 42(6):574-581.
11. Bailey K., Fry R.C. Long-term health consequences of prenatal arsenic exposure: links to the genome and the epigenome?. Rev. Environ Health. 2014, 29(1-2):9-12.
12. Ballentine R., Burford D.D. Determination of metals. Methods Enzymol. 1957, 3:1002-1035.
13. Bal-Price A.K., Kinsner-Ovaskainen A., Coecke S., Hartung T., Hogberg H. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol. Sci. 2010, 113(1):95-115.
14. Bardullas U., Limón-Pacheco J.H., Giordano M., Carrizales L., Mendoza-Trejo M.S., Rodríguez V.M. Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol. Appl. Pharmacol. 2009, 239(2):169-177.
15. Barton A., McLean B. An unusual case of peripheral neuropathy possibly due to arsenic toxicity secondary to excessive intake of dietary supplements. Ann. Clin. Biochem. 2013, 50(Pt 5):496-500.
16. Batandier C., Fontaine E., Kériel C., Leverve X.M. Determination of mitochondrial reactive oxygen species: methodological aspects. J. Cell. Mol. Med. 2002, 6(April-June (2)):175-187.
17. Bau D.T., Wang T.S., Chung C.H., Wang A.S., Wang A.S., Jan K.Y. Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. Environ. Health Perspect. 2002, 110(Suppl. 5):753-756.
18. Bellinger D.C. Inorganic arsenic exposure and children's neurodevelopment: a review of the evidence. Toxics 2013, 1:2-17.
19. Bellinger D.C. Prenatal exposures to environmental chemicals and children's neurodevelopment: an update. Saf. Health Work 2013, 4(1):1-11.
20. Bondy S.C., Tilson H.A., Agrawal A.K. Neurotransmitter receptors in brain regions of acrylamide-treated rats. II: Effects of extended exposure to acrylamide. Pharmacol. Biochem. Behav. 1981, 14(4):533-537.
21. Bortolozzi A.A., Evangelista De Duffard A.M., Duffard R.O., Antonelli M.C. Effects of 2,4-dichlorophenoxyacetic acid exposure on dopamine D2-like receptors in rat brain. Neurotoxicol. Teratol. 2004, 26(4):599-605.
22. Brinkel J.M., Khan M.H., Kraemer A.A. Systematic review of arsenic exposure and its social and mental health effects with special reference to Bangladesh. Int. J. Environ. Res. Public Health 2009, 6:1609-1619.
23. Calderón-Garcidueñas L., Serrano-Sierra A., Torres-Jardón R., Zhu H., Yuan Y., Smith D., Delgado-Chávez R., Cross J.V., Medina-Cortina H., Kavanaugh M., Guilarte T.R. The impact of environmental metals in young urbanites' brains. Exp. Toxicol. Pathol. 2013, 65:503-511.
24. Chandravanshi L.P., Yadav R.S., Shukla R.K., Singh A., Sultana S., Pant A.B., Parmar D., Khanna V.K. Reversibility of changes in brain cholinergic receptors and acetylcholinesterase activity in rats following early life arsenic exposure. Int. J. Dev. Neurosci. 2014, 34:60-75.
25. Chattopadhyay S., Bhaumik S., Nag Chaudhury A., Das Gupta S. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol. Lett. 2002, 128::73-84.
26. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., Argos M., Islam T., Ahmed A., Rakibuz-Zaman M. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011, 342:d2431.
27. Clark J.B., Bates T.E., Boakye P., Kuimov A., Land J.M. Investigation of mitochondrial defects in brain and skeletal muscle. Neurochemistry: A Practical Approach 1997, 151-174. Oxford University Press, Oxford. A.J. Turner, H.S. Bachelard (Eds.).
28. Costa L.G. Developmental neuropathology of environmental agents. Ann. Rev. Pharmacol. Toxicol. 2004, 44:87-110.
29. Davie C.A. A review of Parkinson's disease. Br. Med. Bull. 2008, 86:109-127.
30. Davis M.A., Mackenzie T.A., Cottingham K.L., Gilbert-Diamond D., Punshon T., Karagas M.R. Rice consumption and urinary arsenic concentrations in U.S. children. Environ. Health Perspect. 2012, 120(10):1418-1424.
31. Dhar P., Jaitley M., Kalaivani M., Mehra R.D. Preliminary morphological and histochemical changes in rat spinal cord neurons following arsenic ingestion. Neurotoxicology 2005, 26:309-320.
32. Dong J., Su S.Y. The association between arsenic and children's intelligence: a meta-analysis?. Biol. Trace Elem. Res. 2009, 129(1-3):88-93. Summer.
33. Du J., Zhou N., Liu H., Jiang F., Wang Y., Hu C., Qi H., Zhong C., Wang X., Li Z. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS ONE 2012, 7(4):e35957.
34. Dwivedi N., Mehta A., Yadav A., Binukumar B.K., Gill K.D., Flora S.J. MiADMSA reverses impaired mitochondrial energy metabolism and neuronal apoptotic cell death after arsenic exposure in rats. Toxicol. Appl. Pharmacol. 2011, 1(256(3)):241-248.
35. Eisenegger C., Naef M., Linssen A., Clark L., Gandamaneni P.K., Müller U., Robbins T.W. Role of dopamine D2 receptors in human reinforcement learning. Neuropsychopharmacology 2014, [Epub ahead of print].
36. Flohe L., Gunzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
37. Flora S.J., Bhadauria S., Pant S.C., Dhaked R.K. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life Sci. 2005, 16(77(18)):2324-2337.
38. Flora S.J., Bhatt K., Mehta A. Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats. Toxicol. Appl. Pharmacol. 2009, 240(2):236-244.
39. Fowler B.A., Sexton M.J. Gallium and semiconductor compounds. Handbook on the Toxicology of Metals 2007, 547-555. Academic Press Inc., NY. M. Nordberg (Ed.).
40. García-Chávez E., Santamaría A., Díaz-Barriga F., Mandeville P., Juárez B.I., Jiménez-Capdeville M.E. Arsenite-induced formation of hydroxyl radical in the striatum of awake rats. Brain Res. 2003, 20(976(1)):82-89.
41. García-Chávez E., Segura B., Merchant H., Jiménez I., Del Razo L.M. Functional and morphological effects of repeated sodium arsenite exposure on rat peripheral sensory nerves. J. Neurol. Sci. 2007, 15(258(1-2)):104-110.
42. Girault J., Greengard P. The neurobiology of dopamine signaling. Arch. Neurol. 2004, 61(5):641-644.
43. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 1966, 13(8):655-659.
44. Goggin S.L., Labrecque M.T., Allan A.M. Perinatal exposure to 50 ppb sodium arsenate induces hypothalamic-pituitary-adrenal axis dysregulation in male C57BL/6 mice. Neurotoxicology 2012, 33(5):1338-1345.
45. Hamadani J.D., Tofail F., Nermell B., Gardner R., Shiraji S., Bottai M., Arifeen S.E., Huda S.N., Vahter M. Critical windows of exposure for arsenic-associated impairment of cognitive function in preschool girls and boys: a population based cohort study. Int. J. Epidemiol. 2011, 40:1593-1604.
46. Haque R., Mazumder D.N., Samanta S., Ghosh N., Kalman D., Smith M.M., Mitra S., Santra A., Lahiri S., Das S., De B.K., Smith A.H. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 2003, 14(2):174-182.
47. Hasan M., Haider S.S. Acetyl homocysteine thiolactone protect against some neurotoxic effects of thallium. Neurotoxicology 1989, 10:257-262.
48. Hatefi Y. Preparation and properties of NADH: ubiquinone oxidoreductase (complex I) E.C. 1, 6, 5, 3. Methods Enzymol. 1978, 53:11-15.
49. Hinhumpatch P., Navasumrit P., Chaisatra K., Promvijit J., Mahidol C., Ruchirawat M. Oxidative DNA damage and repair in children exposed to low levels of arsenic in utero and during early childhood: application of salivary and urinary biomarkers. Toxicol. Appl. Pharmacol. 2013, 15(273(3)):569-579.
50. Hsieh R.L., Huang Y.L., Shiue H.S., Huang S.R., Lin M.I., Mu S.C., Chung C.J., Hsueh Y.M. Arsenic methylation capacity and developmental delay in preschool children in Taiwan. Int. J. Hyg. Environ. Health 2014, S1438-4639(14)00016-9.
51. Hughes M.F., Beck B.D., Chen Y., Lewis A.S., Thomas D.J. Arsenic exposure and toxicology: a historical perspective. Toxicol. Sci. 2011, 123(2):305-332.
52. Itoh T., Zhang Y.F., Murai S., Saito H., Nagahama H., Miyate H., et al. The effect of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicol. Lett. 1990, 54:345-353.
53. Jackson B.P., Taylor V.F., Karagas M.R., Punshon T., Cottingham K.L. Arsenic, organic foods, and brown rice syrup. Environ. Health Perspect. 2012, 120(5):623-626.
54. Jamal M., Ameno K., Ameno S., Morishita J., Wang W., Kumihashi M. Changes in cholinergic function in the frontal cortex and hippocampus of rat exposed to ethanol and acetaldehyde. Neuroscience 2007, 144(January (1)):232-238.
55. Jia X., Liu Q., Zhang Y., Dai Y., Duan H., Bin P., Niu Y., Liu J., Zhong L., Guo J., Liu X., Zheng Y. Myelin protein zero and its antibody in serum as biomarkers of n-hexane-induced peripheral neuropathy and neurotoxicity effects. Chin. Med. J. (Engl.) 2014, 127(8):1536-1540.
56. Jin Y., Xi S., Li X., Lu C., Li G., Xu Y., Qu C., Niu Y., Sun G. Arsenic speciation transported through the placenta from mother mice to their newborn pups. Environ Res. 2006, 101:349-355.
57. Jomova K., Jenisova Z., Feszterova M., Baros S., Liska J., Hudecova D., Rhodes C.J., Valko M. Arsenic: toxicity, oxidative stress and human disease. J. Appl. Toxicol. 2011, 31(2):95-107.
58. Jovanović D.D., Paunović K., Manojlović D.D., Jakovljević B., Rasic-Milutinović Z., Dojcinović B.P. Arsenic in drinking water and acute coronary syndrome in Zrenjanin municipality, Serbia. Environ. Res. 2012, 117:75-82.
59. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys. 1984, 21:130-132.
60. Kann O., Kovács R. Mitochondria and neuronal activity. Am. J. Physiol. Cell Physiol. 2007, 292(2):C641-C657.
61. Kanthasamy A.G., Kitazawa M., Yang Y., Anantharam V., Kanthasamy A. Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease. Mol. Brain 2008, 22(1):12.
62. Kapaj S., Peterson H., Liber K., Bhattacharya P. Human health effects from chronic arsenic poisoning -a review. J. Environ. Sci. Health A 2006, 41:2399-2428.
63. Kapoor N., Pant A.B., Dhawan A., Dwievedi U.N., Gupta Y.K., Seth P.K., Parmar D. Differences in sensitivity of cultured rat brain neuronal and glial cytochrome P450 2E1 to ethanol. Life Sci. 2006, 79(16):1514-1522.
64. Katoh Y., Sato T., Yamamoto Y. Determination of multielement concentrations in normal human organs from the Japanese. Biol. Trace Elem. Res. 2002, 90:57-70.
65. Khanna V.K., Husain R., Seth P.K. Effect of protein malnutrition on the neurobehavioral toxicity of styrene in young rats. J. Appl. Toxicol. 1994, 14:351-356.
66. Kris F. Nutrient protection against arsenic toxicity: folate, cysteine support methylation in children. Environ. Health Perspect. 2009, 117(5):A211.
67. Lanphear B.P., Wright R.O., Dietrich K.N. Environmental neurotoxins. Pediatr. Rev. 2005, 26(6):191-197.
68. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-478.
69. Ling I.H., Gwo-Shing C., Chih-Hung L., Tse-Yen Y., Yu-Hsin C., Yuan-Hung W., Yu-Mei H., Hung-Yi C., Meei-Maan W., Chien-Jen C. Use of Arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent. Intern. Malig. Am. J. Epidemiol. 2013, 177(3):202-212.
70. Liu X., Piao F., Li Y. Protective effect of taurine on the decreased biogenic amine neurotransmitter levels in the brain of mice exposed to arsenic. Adv. Exp. Med. Biol. 2013, 776:277-287.
71. Liu X., Zheng Y., Zhang W., Zhang X., Lioyd-Jones D.M., Baccarelli .A.A., Ning H., Fornage M., He K., Liu K., Hou L. Blood methylomics in response to arsenic exposure in a low-exposed US population. J. Expo. Sci. Environ. Epidemiol. 2014, 24(2):145-149.
72. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 192:265-275.
73. Lu T.H., Tseng T.J., Su C.C., Tang F.C., Yen C.C., Liu Y.Y., Yang C.Y., Wu C.C., Chen K.L., Hung D.Z., Chen Y.W. Toxicol. Lett. 2014, January, 3(224(1)):130-140.
74. Mahram M., Shahsavari D., Oveisi S., Jalilolghadr S. Comparison of hypertension and diabetes mellitus prevalence in areas with and without water arsenic contamination. J. Res. Med. Sci. 2013, 18(5):408-412.
75. Mari M., Nadal M., Schuhmacher M., Barbería E., García F., Domingo J.L. Human exposure to metals: levels in autopsy tissues of individuals living near a hazardous waste incinerator. Biol. Trace Elem. Res. 2014, 159:15-21.
76. Markowski V.P., Reeve E.A., Onos K., Assadollahzadeh M., McKay N. Effects of prenatal exposure to sodium arsenite on motor and food-motivated behaviors from birth to adulthood in C57BL6/J mice. Neurotoxicol. Teratol. 2012, 34(2):221-231.
77. Martínez L., Jiménez V., García-Sepúlveda C., Ceballos F., Delgado J.M., Niño-Moreno P., Doniz L., Saavedra-Alanís V., Castillo C.G., Santoyo M.E., González-Amaro R., Jiménez-Capdeville M.E. Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity. Neurochem. Int. 2011, 58(5):574-581.
78. Mathew L., Vale A., Adcock J.E. Arsenical peripheral neuropathy. Pract. Neurol. 2010, 10(1):34-38.
79. Mishra D., Flora S.J.S. Differential oxidative stress and DNA damage in rat brain regions and blood following chronic arsenic exposure. Toxicol. Ind. Health 2008, 24:247-256.
80. Negishi T., Matsunaga Y., Kobayashi Y., Hirano S., Tashiro T. Developmental subchronic exposure to diphenylarsinic acid induced increased exploratory behavior, impaired learning behavior, and decreased cerebellar glutathione concentration in rats. Toxicol. Sci. 2013, 136(2):478-486.
81. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
82. Parajuli R.P., Fujiwara T., Umezaki M., Watanabe C. Association of cord blood levels of lead, arsenic, and zinc with neurodevelopmental indicators in newborns: a birth cohort study in Chitwan Valley, Nepal. Environ. Res. 2013, 121:45-51.
83. Parvez F., Wasserman G.A., Factor-Litvak P., Liu X., Slavkovich V., Siddique A.B., Sultana R., Sultana R., Islam T., Levy D., Mey J.L., Van Geen A., Khan K., Kline J., Ahsan H., Graziano J.H. Arsenic exposure and motor function among children in Bangladesh. Environ. Health Perspect. 2011, 119(11):1665-1670.
84. Piao F., Ma N., Hiraku Y., Murata M., Oikawa S., Cheng F. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J. Occup. Health 2005, 47:445-449.
85. Pineda-Zavaleta A.P., García-Vargas G., Borja-Aburto V.H., Acosta-Saavedra L.C., Vera Aguilar E., Gómez-Muñoz A., Cebrián M.E., Calderón-Aranda E.S. Nitric oxide and superoxide anion production in monocytes from children exposed to arsenic and lead in region Lagunera, Mexico. Toxicol. Appl. Pharmacol. 2004, 198(3):283-290.
86. Rahman A., Vahter M., Ekstrom E.C., Rahman M., Golam Mustafa A.H., Wahed M.A., Yunus M., Persson L.A. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am. J. Epidemiol. 2007, 165:1389-1396.
87. Rahman M.M., Naidu R., Bhattacharya P. Arsenic contamination in groundwater in the Southeast Asia region. Environ. Geochem. Health 2009, 311:9-21.
88. Rahman A., Persson L.Å., Nermell B., E.l.Arifeen S., Ekström E.C., Smith A.H., Vahter M. Arsenic exposure and risk of spontaneous abortion, stillbirth, and infant mortality. Epidemiology 2010, 21(6):797-804.
89. Ram Kumar M., Flora S.J., Reddy G.R. Monoisoamyl 2,3-dimercaptosuccinic acid attenuates arsenic induced toxicity: behavioral and neurochemical approach. Environ. Toxicol. Pharmacol. 2013, 36(1):231-242.
90. Raqib R., Ahmed S., Sultana R., Wagatsuma Y., Mondal D., Hoque A.M., Nermell B., Yunus M., Roy S., Persson L.A., Arifeen S.E., Moore S., Vahter M. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol. Lett. 2009, 28(185(3)):197-202.
91. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 2000, 108(Supplement 3):511-533.
92. Rios R., Zarazua S., Santoyo M.E., Sepulveda-Saavedra J., Romero-Diaz V., Jimenez V., Perez-Severiano F., Vidal-Cantu G., Delgado J.M., Jimenez-Capdeville M.E. Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats. Toxicology 2009, 261(1-2):68-75.
93. Rocha R.A., Gimeno-Alcañiz J.V., Martín-Ibañez R., Canals J.M., Vélez D., Devesa V. Arsenic and fluoride induce neural progenitor cell apoptosis. Toxicol. Lett. 2011, 203(3):237-244.
94. Rocha-Amador D., Navarro M.E., Carrizales L., Morales R., Calderón J. Decreased intelligence in children and exposure to fluoride and arsenic in drinking water. Cad. Saude Publica 2007, 23(Suppl. 4):S579L 87.
95. Rodriguez V.M., Dufour L., Carrizales L., Diaz-Barriga F., Jimenez-Capdeville M.E. Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environ. Health Perspect. 1998, 106:487-491.
96. Rodriguez V.M., Carrizales L., Mendoza M.S., Fajardo O.R., Giordano M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol. Teratol. 2002, 24:743-750.
97. Rodriguez V.M., Del Razo L.M., Limon-Pacheco J.H., Giordano M., Sanchez-Pena L.C., Uribe-Querol E., Gutierrez-Ospina G., Gonsebatt M.E. Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver. Toxicol. Sci. 2005, 84(1):157-166.
98. Rodriguez V.M., Limon-Pacheco J.H., Carrizales L., Mendoza-Trejo M.S., Giordano M. Chronic exposure to low levels of inorganic arsenic causes alterations in locomotoractivity and in the expression of dopaminergic and antioxidant systems in the albino rat. Neurotoxicol. Teratol. 2010, 32(6):640-647.
99. Rosado J.L., Ronquillo D., Kordas K., Rojas O., Alatorre J., Lopez P., Garcia-Vargas G., Del Carmen Caamãno M., Cebrián M.E., Stoltzfus R.J. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ. Health Perspect. 2007, 115(9):1371-1375.
100. Rosso J.J., Schenone N.F., Carrera A.P., Fernandez Cirelli A. Concentration of arsenic in water, sediments and fish species from naturally contaminated rivers. Environ. Geochem. Health 2013, 35:201-214.
101. Roy A., Kordas K., Lopez P., Rosado J.L., Cebrian M.E., Vargas G.G., Ronquillo D., Stoltzfus R.J. Association between arsenic exposure and behavior among 636 first-graders from Torreon, Mexico. Environ. Res. 2011, 111:670-676.
102. Rush J.W., Quadrilatero J., Levy A.S., Ford R.J. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp. Biol. Med. (Maywood) 2007, 232(6):814-822.
103. Saha D., Shukla R.R. Genesis of arsenic-rich groundwater and the search for alternative safe aquifers in the Gangetic Plain, India. Water Environ. 2013, 85(12):2254-2264.
104. Samuel S., Kathirvel R., Jayavelu T., Chinnakkannu P. Protein oxidative damage in arsenic induced rat brain: influence of dl-alpha-lipoic acid. Toxicol. Lett. 2005, 155:27-34.
105. Sankhwar M.L., Yadav R.S., Shukla R.K., Singh D., Ansari R.W., Pant A.B., Parmar D., Khanna V.K. Monocrotophos induced oxidative stress and alterations in brain dopamine and serotonin receptors in young rats. Toxicol. Ind. Health 2013, [Epub ahead of print].
106. Seeman P., Weinshenker D., Quirion R., Srivastava L.K., Bhardwaj S.K., Grandy D.K., Premont R.T., Sotnikova T.D., Boksa P., El-Ghundi M. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3513-3518.
107. Seeman P., Ko F., Jack E., Greenstein R., Dean B. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse 2007, 61(5):303-309.
108. Sharma H., Zhang P., Barber D.S., Liu B. Organochlorine pesticides dieldrin and lindane induce cooperative toxicity in dopaminergic neurons: role of oxidative stress. Neurotoxicology 2010, 31(2):215-222.
109. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., Chen Y., Shi X., Liu K.J. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 2004, 17(7):871-878.
110. Shohamy D., Adcock R.A. Dopamine and adaptive memory. Trends Cogn. Sci. 2010, 14(10):464-472.
111. Siddiqui M.A., Kashyap M.P., Khanna V.K., Yadav S., Al-Khedhairy A.A., Musarrat J., Pant A.B. Association of dopamine DA-D2 receptor in rotenone-induced cytotoxicity in PC12 cells. Toxicol. Ind. Health 2010, 26(8):533-542.
112. Singh A.P., Goel R.K., Kaur T. Mechanisms pertaining to arsenic toxicity. Toxicol. Int. 2011, 18(2):87-93.
113. Siripitayakunkit U., Visudhiphan P., Pradipasen M., Vorapongsathon T. Association between chronic arsenic exposure and children's intelligence in Thailand. Arsenic Exposure and Health effects 1999, 141-150. Elsevier, New York. W.R. Chappell, C.O. Abernathy, R.L. Calderon (Eds.).
114. Smith A.H., Marshall G., Liaw J., Yuan Y., Ferreccio C., Steinmaus C. Mortality 648 in young adults following in utero and childhood exposure to arsenic in drinking 649 water. Environ. Health Perspect. 2012, 120(11):1527-1531.
115. Stanwood G.D., Levitt P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr. Opin. Pharmacol. 2004, 4:65-71.
116. States J.C., Srivastava S., Chen Y., Barchowsky A. Arsenic and cardiovascular disease. Toxicol. Sci. 2009, 107(2):312-323.
117. Stea F., Bianchi F., Cori L., Sicari R. Cardiovascular effects of arsenic: clinical and epidemiological findings. Environ. Sci. Pollut. Res. Int. 2014, 21(1):244-251.
118. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74(6):289-299.
119. Tait S., Ricceri L., Venerosi A., Maranghi F., Mantovani A., Calamandrei G. Long-term effects on hypothalamic neuropeptides after developmental exposure to chlorpyrifos in mice. Environ. Health Perspect. 2009, 117(1):112-116.
120. Takahashi H., Higuchi M., Suhara T. The role of extrastriatal dopamine D2 receptors in schizophrenia. Biol. Psychiatry 2006, 15(59(10)):919-928.
121. Tsai C.P., Lee C.T. Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan. PLOS ONE 2013, 17(8(6)):e65911.
122. Vahidnia A., van der Straaten R.J., Romijn F., van Pelt J., van der Voet G.B., de Wolff F.A. Arsenic metabolites affect expression of the neurofilament and tau genes: an in vitro study into the mechanism of arsenic neurotoxicity. Toxicol. In Vitro 2007, 21(6):1104-1112.
123. Vahter M. Effects of arsenic on maternal and fetal health. Annu. Rev. Nutr. 2009, 29:381-399.
124. Vall O., Gómez-Culebras M., Garcia-Algar O., Joya X., Velez D., Rodríguez-Carrasco E., Puig C. Assessment of prenatal exposure to arsenic in Tenerife Island. PLoS ONE 2012, 7(11):e50463.
125. Van Geen A., Win K.H., Zaw T., Naing W., Mey J.L., Mailloux B. Confirmation of elevated arsenic levels in groundwater of Myanmar. Sci. Total Environ. 2014, 15(478):21-24.
126. Von Ehrenstein O.S., Poddar S., Yuan Y., Mazumder D.G., Eskenazi B., Basu A. Children's intellectual function in relation to arsenic exposure. Epidemiology 2007, 18:44-51.
127. Wang S.X., Wang Z.H., Cheng X.T., Li J., Sang Z.P., Zhang X.D., Han L.L., Qiao X.Y., Wu Z.M., Wang Z.Q. Arsenic and fluoride exposure in drinking water: children's IQ and growth in Shanyin county, Shanxi province, China. Environ. Health Perspect. 2007, 115:643-647.
128. Wasserman G.A., Liu X., LoIacono N.J., Kline J., Factor-Litvak P., van Geen A., Mey J.L., Levy D., Abramson R., Schwartz A., Graziano J.H. A cross-sectional study of well water arsenic and child IQ in Maine schoolchildren. Environ. Health 2014, 13:23.
129. Weiss B. Vulnerability of children and the developing brain to neurotoxic hazards. Environ. Health Perspect. 2000, 108(Supplement 3):375-381.
130. Wharton D.C., Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 1967, 10:245-250.
131. WHO A field guide for detection, management and surveillance of arsenicosis cases. Technical Publication No. 30 2005, 5-18. WHO, SEARO, New Delhi. D. Caussy (Ed.).
132. Wlodarczyk B.J., Palacios A.M., Chapa C.J., Zhu H., George T.M., Finnell R.H. Genetic basis of susceptibility to teratogen induced birth defects. Am. J. Med. Genet. C: Semin. Med. Genet. 2011, 157(3):215-226.
133. Wright R.O., Amarasiriwardena C., Woolf A.D., Jim R., Bellinger D.C. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 2006, 27(2):210-216.
134. Xi S., Guo L., Qi R., Sun W., Jin Y., Sun G. Prenatal and early life arsenic exposure induced oxidative damage and altered activities and mRNA expressions of neurotransmitter metabolic enzymes in offspring rat brain. J. Biochem. Mol. Toxicol. 2010, 6:368-378.
135. Xi S., Jin Y., Lv X., Sun G. Distribution and speciation of arsenic by transplacental and early life exposure to inorganic arsenic in offspring rats. Biol. Trace Elem. Res. 2010, 134(1):84-97.
136. Yadav R.S., Sankhwar M.L., Shukla R.K., Chandra R., Pant A.B., Islam F., et al. Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicol. Appl. Pharmacol. 2009, 240(3):367-376.
137. Yen C.C., Ho T.J., Wu C.C., Chang C.F., Su C.C., Chen Y.W., Jinn T.R., Lu T.H., Cheng P.W., Su Y.C., Liu S.H., Huang C.F. Inorganic arsenic causes cell apoptosis in mouse cerebrum through an oxidative stress-regulated signaling pathway. Arch. Toxicol. 2011, 85(6):565-575.
138. Yorifuji T., Tsuda T., Doi H., Grandjean P. Cancer excess after arsenic exposure from contaminated milk powder. Environ. Health Prev. Med. 2011, 16(3):164-170.
139. Zarazua S., Rios R., Delgado J.M., Santoyo M.E., Ortiz-Perez D., Jimenez-Capdeville M.E. Decreased arginine methylation and myelin alterations in arsenic exposed rats. Neurotoxicology 2010, 31(1):94-100.
140. Zhang J., Liu X., Zhao L., Hu S., Li S., Piao F. Subchronic exposure to arsenic disturbed the biogenic amine neurotransmitter level and the mRNA expression of synthetase in mice brains. Neuroscience 2013, 25(241):52-58.